0000950123-23-009395.txt : 20231103 0000950123-23-009395.hdr.sgml : 20231103 20231103171003 ACCESSION NUMBER: 0000950123-23-009395 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 EFFECTIVENESS DATE: 20231103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 231377300 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001560009 XXXXXXXX 09-30-2023 09-30-2023 false Versant Venture Management, LLC

One Sansome Street, Suite 1650 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 000161130 802-75823 N Max Eisenberg (415) 801-8100 /s/ Max Eisenberg San Francisco CA 11-03-2023 0 8 188112040 false INFORMATION TABLE 2 27610.xml INFORMATION TABLE FOR FORM 13F Adverum Biotechnologies, Inc. Common Stock 00773U108 7602350 5068233 SH OTR 0 5068233 0 Aligos Therapeutics, Inc. Common Stock 01626L105 1733325 2320381 SH OTR 0 2320381 0 CRISPR Therapeutics AG Common Shares H17182108 22629548 498558 SH OTR 0 498558 0 Gritstone Oncology, Inc. Common Stock 39868T105 6125178 3561150 SH OTR 0 3561150 0 Minerva Surgical Inc. Common Stock 60343F106 275320 83684 SH OTR 0 83684 0 Passage Bio, Inc. Common Stock 702712100 3263528 4959769 SH OTR 0 4959769 0 RayzeBio, Inc. Common Stock 75525N107 114511174 5158161 SH OTR 0 5158161 0 Repare Therapeutics, Inc. Common Stock 760273102 31971617 2646657 SH OTR 0 2646657 0